免疫调节在支气管扩张症发病机制中的研究进展
Research Progress of Immune Regulation in the Pathogenesis of Bronchiectasis
DOI: 10.12677/ACM.2023.132314, PDF,   
作者: 于 洋*:青海大学研究生院,青海 西宁;李玉红:青海大学附属医院呼吸科,青海 西宁
关键词: 支气管扩张症免疫调节发病机制Bronchiectasis Immune Regulation Pathogenesis
摘要: 支气管扩张症是由各种疾病引起反复发生的化脓性感染,导致中小气管反复损伤和/或阻塞,致使支气管壁结构破坏,引起支气管异常和持续性扩张。支气管扩张症的病因诸多,这些因素都直接或间接损害了宿主防御能力,反复性细菌感染和炎症反应失调导致了进行性肺损伤。其中炎症反应在肺部产生的蛋白酶会损害气道并导致病理性扩张,是整个宿主防御受损的关键,并与机体免疫功能存在关联,以免疫损害、免疫炎性反应等形式对机体产生侵害。本文着重讨论了支气管扩张症发病机制中的免疫学因素及相关免疫反应,为进一步研究提供理论依据。
Abstract: Bronchiectasis is a recurrent suppurative infection caused by various diseases, resulting in repeat-ed injury and/or obstruction of small and medium-sized trachea, resulting in the destruction of bronchial wall structure, causing bronchial abnormalities and persistent dilation. There are many causes of bronchiectasis. These factors directly or indirectly damage the host’s defense ability. Re-peated bacterial infection and inflammatory reaction disorder lead to progressive lung injury. Among them, the protease produced by inflammatory reaction in the lung will damage the airway and cause pathological expansion, which is the key to the damage of the whole host’s defense, and is associated with the body’s immune function, which will harm the body in the form of immune dam-age, immune inflammatory reaction, etc. This article focuses on the immunological factors and re-lated immune reactions in the pathogenesis of bronchiectasis, providing theoretical basis for fur-ther research.
文章引用:于洋, 李玉红. 免疫调节在支气管扩张症发病机制中的研究进展[J]. 临床医学进展, 2023, 13(2): 2241-2253. https://doi.org/10.12677/ACM.2023.132314

参考文献

[1] Boyton, R.J., Reynolds, C.J., Quigley, K.J. and Altmann, D.M. (2013) Immune Mechanisms and the Impact of the Dis-rupted Lung Microbiome in Chronic Bacterial Lung Infection and Bronchiectasis. Clinical and Experimental Immunology, 171, 117-123. [Google Scholar] [CrossRef] [PubMed]
[2] 孙雪峰, 高金明. 非囊性纤维化性支气管扩张症的免疫调节机制[J]. 国际呼吸杂志, 2014, 34(4): 303-309. [Google Scholar] [CrossRef
[3] Barker, A.F. (2002) Bronchiectasis. The New England Journal of Medicine, 346, 1383-1393. [Google Scholar] [CrossRef
[4] Wilson, R., Boyton, R., Laurent, G.J. and Shapiro, S.D. (2006) Bronchiectasis. In: Encyclopedia of Respiratory Medicine, Elsevier, Oxford, UK, 259-268. [Google Scholar] [CrossRef
[5] Boyton, R.J. (2009) Regulation of Immunity in Bronchiec-tasis. Medical Mycology, 47, S175-S182. [Google Scholar] [CrossRef] [PubMed]
[6] Martinez-Garcia, M.Á., Oscullo, G. and Garcia-Ortega, A. (2022) Towards a New Definition of Non-Cystic Fibrosis Bronchiectasis. Jornal Brasileiro de Pneumologia, 48, e20220023. [Google Scholar] [CrossRef] [PubMed]
[7] Feng, J., Sun, L., Sun, X., Xu, L., Liu, L., Liu, G., Wang, J., Gao, P., Zhan, S., Chen, Y., Wang, S. and Sun, Y. (2022) Increasing Prevalence and Burden of Bronchiectasis in Urban Chinese Adults, 2013-2017: A Nationwide Population-Based Cohort Study. Respiratory Research, 23, Article No. 111. [Google Scholar] [CrossRef] [PubMed]
[8] Barker, A.F. and Bardana Jr., E.J. (1988) Bronchiecta-sis: Update of an Orphan Disease. American Review of Respiratory Disease, 137, 969-978. [Google Scholar] [CrossRef] [PubMed]
[9] 张艳芳, 冯广满. 大环内酯类药物联合阿米卡星对支气管扩张患者PA形成生物膜的清除作用[J]. 热带医学杂志2017, 17(2): 1593-1596.
[10] 程克斌, 徐金富, 李惠萍. 支气管扩张症的免疫调节机制及其免疫调节治疗进展[J]. 国际呼吸杂志, 2019, 39(6): 457-461.
[11] Cole, P.J. (1986) Inflammation: A Two-Edged Sword—The Model of Bronchiectasis. European Journal of Respiratory Diseases. Sup-plement, 147, 6-15.
[12] Chalmers, J.D., Chang, A.B., Chotirmall, S.H., et al. (2018) Bronchiectasis. Nature Reviews Disease Primers, 4, Article No. 45. [Google Scholar] [CrossRef] [PubMed]
[13] Muñoz, G., de Gracia, J., Buxó, M., et al. (2018) Long-Term Benefits of Airway Clearance in Bronchiectasis: A Randomised Placebo-Controlled Trial. European Respiratory Journal, 51, Article ID: 1701926. [Google Scholar] [CrossRef] [PubMed]
[14] Chalmers, J.D., Boersma, W., Lonergan, M., et al. (2019) Long-Term Macrolide Antibiotics for the Treatment of Bronchiectasis in Adults: An Individual Participant Data Me-ta-Analysis. The Lancet Respiratory Medicine, 7, 845-854. [Google Scholar] [CrossRef
[15] Haworth, C.S., Bilton, D., Chalmers, J.D., et al. (2019) In-haled Liposomal Ciprofloxacin in Patients with Non-Cystic Fibrosis Bronchiectasis and Chronic Lung Infection with Pseudomonas aeruginosa (ORBIT-3 and ORBIT-4): Two Phase 3, Randomised Controlled Trials. The Lancet Respira-tory Medicine, 7, 213-226. [Google Scholar] [CrossRef
[16] Flume, P.A., Chalmers, J.D. and Olivier, K.N. (2018) Ad-vances in Bronchiectasis: Endotyping, Genetics, Microbiome, and Disease Heterogeneity. The Lancet, 392, 880-890. [Google Scholar] [CrossRef
[17] Xu, J.F., Gao, Y.H., Song, Y.L., Qu, J.M. and Guan, W.J. (2022) Research Advances and Clinical Management of Bronchiectasis: Chinese Perspective. ERJ Open Research, 8, Ar-ticle ID: 00017-2022. [Google Scholar] [CrossRef] [PubMed]
[18] Angrill, J., Agustí, C., De Celis, R., et al. (2002) Bacterial Colonisation in Patients with Bronchiectasis: Microbiological Pattern and Risk Factors. Thorax, 57, 15-19. [Google Scholar] [CrossRef] [PubMed]
[19] Watt, A.P., Brown, V., Courtney, J., et al. (2004) Neutrophil Apoptosis, Proinflammatory Mediators and Cell Counts in Bronchiectasis. Thorax, 59, 231-236. [Google Scholar] [CrossRef] [PubMed]
[20] King, P.T. (2018) The Role of the Immune Response in the Patho-genesis of Bronchiectasis. BioMed Research International, 2018, Article ID: 6802637. [Google Scholar] [CrossRef] [PubMed]
[21] Whitters, D. and Stockley, R. (2012) Immunity and Bacterial Colonisa-tion in Bronchiectasis. Thorax, 67, 1006-1013. [Google Scholar] [CrossRef] [PubMed]
[22] Cowburn, A.S., Condliffe, A.M., Farahi, N., et al. (2008) Ad-vances in Neutrophil Biology: clinical Implications. Chest, 134, 606-612. [Google Scholar] [CrossRef] [PubMed]
[23] Stockley, R.A. (2002) Neutrophils and the Pathogenesis of COPD. Chest, 121, 151S-155S. [Google Scholar] [CrossRef
[24] Mikami, M., Llewellyn-Jones, C.G., Bayley, D., et al. (1998) The Chemotactic Activity of Sputum from Patients with Bronchiectasis. American Journal of Respiratory and Critical Care Medicine, 157, 723-728. [Google Scholar] [CrossRef] [PubMed]
[25] Mitchell, T., Lo, A., Logan, M.R., et al. (2008) Primary Gran-ule Exocytosis in Human Neutrophils Is Regulated by Rac-Dependent Actin Remodelling. American Journal of Physiol-ogy—Cell Physiology, 295, C1354-C1365. [Google Scholar] [CrossRef] [PubMed]
[26] Rosenzweig, S.D. (2008) Inflammatory Manifestations in Chronic Granulomatous Disease. Journal of Clinical Immunology, 28, S67-S72. [Google Scholar] [CrossRef] [PubMed]
[27] Reeves, E.P., Lu, H., Jacobs, H.L., et al. (2002) Killing Activity of Neutrophils Is Mediated through Activation of Proteases by Flux. Nature, 416, 291-297. [Google Scholar] [CrossRef] [PubMed]
[28] Tung, J.P., Fraser, J.F., Wood, P., et al. (2009) Respiratory Burst Function of Ovine Neurophils. BMC Immunology, 10, Article No. 25. [Google Scholar] [CrossRef] [PubMed]
[29] Zheng, L., Shum, I.H., Tipoe, G.L., et al. (2001) Macrophages, Neutrophils and Tumour Necrosis Factor-α Expression in Bronchi-ectatic Airways in Vivo. Respiratory Medicine, 95, 792-798. [Google Scholar] [CrossRef] [PubMed]
[30] Stockley, R.A., Hill, S.L., Morrison, H.M. and Starkie, C.M. (1984) Elastolytic Activity of Sputum and Its Relation to Purulence and to Lung Function in Patients with Bronchiectasis. Thorax, 39, 408-413. [Google Scholar] [CrossRef] [PubMed]
[31] Shum, D.K.Y., Chan, S.C.H. and Ip, M.S.M. (2000) Neutro-phil-Mediated Degradation of Lung Proteoglycans: Stimulation by Tumor Necrosis Factor-α in Sputum of Patients with Bronchiectasis. American Journal of Respiratory and Critical Care Medicine, 162, 1925-1931. [Google Scholar] [CrossRef] [PubMed]
[32] Paulson, M.L., Freeman, A.F. and Holland, S.M. (2008) Hyper IgE Syndrome: An Update on Clinical Aspects and the Role of Signal Transducer and Activator of Transcription 3. Cur-rent Opinion in Allergy and Clinical Immunology, 8, 527-533. [Google Scholar] [CrossRef
[33] Wood, A.M., Bassford, C., Webster, D., et al. (2011) Vita-min D-Binding Protein Contributes to COPD by Activation of Alveolar Macrophages. Thorax, 66, 205-210. [Google Scholar] [CrossRef] [PubMed]
[34] Whitwell, F. (1952) A Study of the Pathology and Pathogenesis of Bronchiectasis. Thorax, 7, 213-239. [Google Scholar] [CrossRef] [PubMed]
[35] Silva Jones Jr., J.A., Cole, P.J. and Poulter, L.W. (1989) The Immunolog-ical Component of the Cellular Inflammatory Infiltrate in Bronchiectasis. Thorax, 44, 668-673. [Google Scholar] [CrossRef] [PubMed]
[36] Sepper, R., Konttinen, Y.T., Ingman, T. and Sorsa, T. (1995) Presence, Activities, and Molecular Forms of Cathepsin G, Elastase, α1-Antitrypsin, and α1-Antichymotrypsin in Bronchiectasis. Journal of Clinical Immunology, 15, 27-34. [Google Scholar] [CrossRef
[37] Frija-Masson, J., Martin, C., Regard, L., et al. (2017) Bacteria-Driven Peribronchial Lymphoid Neogenesis in Bronchiectasis and Cystic Fibrosis. European Respiratory Journal, 49, Article ID: 1601873. [Google Scholar] [CrossRef] [PubMed]
[38] Lapa, E., Silva, J.R., Guerreiro, D., Noble, B., et al. (1989) Immunopathology of Experimental Bronchiectasis. The American Journal of Respiratory Cell and Molecular Biology, 1, 297-304. [Google Scholar] [CrossRef] [PubMed]
[39] Eller, J., Lapa, E., Silva, J.R., Poulter, L.W., et al. (1994) Cells and Cytokines in Chronic Bronchial Infection. Annals of the New York Academy of Sciences, 725, 331-345. [Google Scholar] [CrossRef] [PubMed]
[40] Mukae, H., Kadota, J., Kohno, S., et al. (1995) Increase in Activated CD8+ Cells in Bronchoalveolar Lavage Fluid in Patients with Diffuse Panbronchiolitis. American Journal of Respiratory and Critical Care Medicine, 152, 613-618. [Google Scholar] [CrossRef] [PubMed]
[41] Campbell DA, du Bois RM, Butcher RG, et al. (1986) Density of HLA-DR Antigen Expression on Alveolar Macrophages Is Increased in Pulmonary Sarcoidosis. Clinical and Experi-mental Immunology, 65, 165-171.
[42] Saetta, M., Di Stefano, A., Maestrelli, P., et al. (1993) Activated T-Lymphocytes and Macrophages in Bronchial Mucosa of Subjects with Chronic Bronchitis. American Review of Respiratory Disease, 147, 301-306. [Google Scholar] [CrossRef] [PubMed]
[43] Bentley, A.M., Menz, G., Storz, C., et al. (1992) Identification of T Lymphocytes, Macrophages and Activated Eosinophils in the Bronchial Mucosa in Intrinsic Asthma. American Review of Respiratory Disease, 146, 500-506. [Google Scholar] [CrossRef] [PubMed]
[44] Azzawi, M., Bradley, B., Jeffery, P.K., et al. (1990) Identification of Activated T Lymphocytes and Eosinophils in Bronchial Biopsies in Stable Atopic Asthma. American Review of Respira-tory Disease, 142, 1407-1413. [Google Scholar] [CrossRef
[45] Poulter, L.W., Russel-Jones, R. and Hobbe, S. (1984) The Significance of Antigen Presenting Cells in Psoriasis. In: Macdonald, D.C., Ed., Immunodermatology, Butterworths, London, 185-188. [Google Scholar] [CrossRef
[46] Poulter, L.W., Duke, O., Panayi, G.S., et al. (1985) Activated T Lymphocytes of the Synovial Membrane in Rheumatoid Arthritis and Other Arthropathies. Scandinavian Journal of Immunology, 22, 683-689. [Google Scholar] [CrossRef] [PubMed]
[47] Poulter, L.W., Allison, M., Rochardson, A.T., et al. (1987) The Distribution of Lymphocyte Subsets in Inflammatory Bowel Disease and Reactive Synovitis: A Comparison. In: Mielants, H. and Veys, E.M., Eds., Spondyloarthropathies: Involvement of the Gut, Elsevier, Amsterdam, 213-220.
[48] Boyton, R.J. and Altmann, D.M. (2016) Bronchiectasis: Current Concepts in Pathogenesis, Immunology, and Microbiology. Annual Review of Pathology: Mechanisms of Disease, 11, 523-554. [Google Scholar] [CrossRef] [PubMed]
[49] Tan, H.-L., Regamey, N., Brown, S., Bush, A., Lloyd, C.M. and Davies, J.C. (2011) The Th17 Pathway in Cystic Fibrosis Lung Disease. American Journal of Respiratory and Critical Care Medicine, 184, 252-258. [Google Scholar] [CrossRef
[50] Zimmer, J., Andres, E., Donato, L., et al. (2005) Clinical and Immunological Aspects of HLA Class I Deficiency. QJM, 98, 719-727. [Google Scholar] [CrossRef] [PubMed]
[51] Bard, M., Couderc, L.J., Saimot, A.G., et al. (1998) Accelerated Ob-structive Pulmonary Disease in HIV Infected Patients with Bronchiectasis. European Respiratory Journal, 11, 771-775. [Google Scholar] [CrossRef
[52] Bekir, M., Karakoç Aydıner, E., Yıldızeli, Ş.O., Öğülür, İ., Kocakaya, D., Barış, S., Eryüksel, E., Özen, A. and Ceyhan, B.B. (2021) Primary Immun Deficiency in Patients with Non-Cystic Fibrosis Bronchiectasis and Its Relationship with Clinical Parameters. Turkish Thoracic Journal, 22, 37-44. [Google Scholar] [CrossRef
[53] Gaga, M., Bentley, A.M., Humbert, M., et al. (1998) In-creases in CD4+ T Lymphocytes, Macrophages, Neutrophils and Interleukin 8 Positive Cells in the Airways of Patients with Bronchiectasis. Thorax, 53, 685-691. [Google Scholar] [CrossRef] [PubMed]
[54] Ip, M., Lauder, I.J., Wong, W.Y., et al. (1993) Multivariate Analysis of Factors Affecting Pulmonary Function in Bronchiectasis. Respiration, 60, 45-50. [Google Scholar] [CrossRef] [PubMed]
[55] De Gracia, J., Rodrigo, M.J., Morell, F., et al. (1996) IgG Subclass Defi-ciencies Associated with Bronchiectasis. American Journal of Respiratory and Critical Care Medicine, 153, 650-655. [Google Scholar] [CrossRef] [PubMed]
[56] Hill, S.L., Mitchell, J.L., Burnett, D. and Stockley, R.A. (1998) IgG Subclasses in the Serum and Sputum from Patients with Bronchiectasis. Thorax, 53, 463-468. [Google Scholar] [CrossRef] [PubMed]
[57] Ooi, G.C., Khong, P.L., Chan-Yeung, M., et al. (2002) High-Resolution CT Quantification of Bronchiectasis: Clinical and Functional Correlation. Radiology, 225, 663-672. [Google Scholar] [CrossRef] [PubMed]
[58] Pasteur, M.C., Helliwell, S.M., Houghton, S.J., et al. (2000) An Investigation into Causative Factors in Patients with Bronchiectasis. American Journal of Respiratory and Critical Care Medicine, 162, 1277-1284. [Google Scholar] [CrossRef] [PubMed]
[59] King, P.T., Hutchinson, P., Holmes, P.W., et al. (2006) As-sessing Immune Function in Adult Bronchiectasis. Clinical & Experimental Immunology, 144, 440-446. [Google Scholar] [CrossRef] [PubMed]
[60] Vendrell, M., de Gracia, J., Rodrigo, M.-J., et al. (2005) Antibody Production Deficiency with Normal IgG Levels in Bronchiectasis of Unknown Etiology. Chest, 127, 197-204. [Google Scholar] [CrossRef] [PubMed]
[61] Pilette, C., Detry, B., Guisset, A., et al. (2006) Dual Effect of Neutro-phils on Secretory Component Production by Human Bronchial Epithelial Cells. European Respiratory Review, 15, 175-176. [Google Scholar] [CrossRef
[62] Burnett, D., Crocker, J. and Stockley, R.A. (1987) Cells contain-Ing IgA Subclasses in Bronchi of Subjects with and without Chronic Obstructive Pulmonary Disease. Journal of Clinical Pathology, 40, 1217-1220. [Google Scholar] [CrossRef] [PubMed]
[63] Burnett, D., Hill, S.L. and Bradwell, A.R. (1990) IgA Subclasses in Sputum from Patients with Bronchiectasis. Respiratory Medicine, 84, 123-127. [Google Scholar] [CrossRef
[64] Skaaby, T., Husemoen, L.L., Thuesen, B.H., et al. (2017) IgE Sensitization to Inhalant Allergens and the Risk of Airway Infection and Disease: A Population-Based Study. PLOS ONE, 12, e0171525. [Google Scholar] [CrossRef] [PubMed]
[65] Chalmers, J.D., McHugh, B.J., Doherty, C., et al. (2013) Man-nose-Binding Lectin Deficiency and Disease Severity in Non-Cystic Fibrosis Bronchiectasis: A Prospective Study. The Lancet Respiratory Medicine, 1, 224-232. [Google Scholar] [CrossRef
[66] Rogan, M.P., Geraghty, P., Green, C.M., et al. (2006) Anti-microbial Proteins and Polypeptides in Pulmonary Innate Defence. Respiratory Research, 7, Article No. 29. [Google Scholar] [CrossRef] [PubMed]
[67] Guan, W.J., Gao, Y.H., Xu, G., et al. (2015) Sputum Bacteriology in Steady-State Bronchiectasis in Guangzhou, China. The International Journal of Tuberculosis and Lung Disease, 19, 610-619. [Google Scholar] [CrossRef] [PubMed]
[68] Asad, S. and Opal, S. (2008) Bench-to-Bedside Review: Quorum Sensing and the Role of Cell-to-Cell Communication during Invasive Bacterial Infection. Critical Care, 12, Ar-ticle No. 236. [Google Scholar] [CrossRef] [PubMed]
[69] Telford, G., Wheeler, D. and Williams, P. (1998) The Pseudo-monas aeruginosa Quorum-Sensing Signal Molecule N- (3-oxododecanoyl)-L-homoserine Lactone Has Immunomodu-latory Activity. Infection and Immunity, 66, 36-42. [Google Scholar] [CrossRef
[70] Ritchie, A.J., Jansson, A., Stallberg, J., et al. (2005) The Pseu-domonas aeruginosa Quorum-Sensing Signal Molecule N-(3-oxododecanoyl)-L-homoserine Lactone Inhibits T-Cell Differentiation and Cytokine Production by a Mechanism Involving an Early Step in T-Cell Activation. Infection and Immunity, 73, 1648-1655. [Google Scholar] [CrossRef
[71] Smith, R.S., Harris, S.G., Phipps, R., et al. (2002) The Pseudomonas aeruginosa Quorum-Sensing Molecule N-(3- Oxododecanoyl)Homoserine Lactone Contributes to Viru-lence and Induces Inflammation in Vivo. Journal of Bacteriology, 184, 1132-1139. [Google Scholar] [CrossRef] [PubMed]
[72] Wang, H., Ji, X.B., Mao, B., et al. (2018) Pseudomonas aeruginosa Isolation in Patients with Non-Cystic Fibrosis Bronchiectasis: A Retrospective Study. BMJ Open, 8, e014613. [Google Scholar] [CrossRef] [PubMed]
[73] Luo, R.G., Miao, X.Y., Luo, L.L., et al. (2019) Presence of pldA and exoU in Mucoid Pseudomonas aeruginosa Is Associated with High Risk of Exacerbations in Non-Cystic Fi-brosis Bronchiectasis Patients. Clinical Microbiology and Infection, 25, 601-606. [Google Scholar] [CrossRef] [PubMed]
[74] Finch, S., McDonnell, M.J., Abo-Leyah, H., et al. (2015) A Com-prehensive Analysis of the Impact of Pseudomonas aeruginosa Colonization on Prognosis in Adult Bronchiectasis. An-nals of the American Thoracic Society, 12, 1602- 1611. [Google Scholar] [CrossRef
[75] Clementi, C.F. and Murphy, T.F. (2011) Non-Typeable Haemophilus influenzae Invasion and Persistence in the Human Respiratory Tract. Frontiers in Cellular and Infection Microbiology, 1, Article 1. [Google Scholar] [CrossRef] [PubMed]
[76] King, P.T., Hutchinson, P.E., Johnson, P.D., Holmes, P.W., Freez-er, N.J. and Holdsworth, S.R. (2003) Adaptive Immunity to Nontypeable Haemophilus influenzae. American Journal of Respiratory and Critical Care Medicine, 167, 587-592. [Google Scholar] [CrossRef
[77] Wynn, T.A. (2004) Fibrotic Disease and the TH1/TH2 Paradigm. Nature Reviews Immunology, 4, 538-594. [Google Scholar] [CrossRef] [PubMed]
[78] Pasteur, M.C., Bilton, D. and Hill, A.T. (2010) British Thoracic Society Guideline for Non-CF Bronchiectasis. Thorax, 65, 577. [Google Scholar] [CrossRef] [PubMed]
[79] Chang, A.B., Bell, S.C., Torzillo, P.J., et al. (2015) Chronic Suppurative Lung Disease and Bronchiectasis in Children and Adults in Australia and New Zealand Thoracic Society of Australia and New Zealand guidelines. Medical Journal of Australia, 202, 130. [Google Scholar] [CrossRef] [PubMed]
[80] Polverino, E., Goeminne, P.C., McDonnell, M.J., et al. (2017) European Respiratory Society Guidelines for the Management of Adult Bronchiectasis. European Respiratory Journal, 50, Article ID: 1700629. [Google Scholar] [CrossRef] [PubMed]
[81] Hill, A.T., Sullivan, A.L., Chalmers, J.D., et al. (2019) British Thoracic Society Guideline for Bronchiectasis in Adults. Thorax, 74, 1-69. [Google Scholar] [CrossRef] [PubMed]
[82] Bronchiectasis Expert Consensus Writing Group, Pulmonary Infection Assembly, Chinese Thoracic Society (2021) [Expert Consensus on the Diagnosis and Treatment of Adult Bronchiectasis in China]. Chinese Journal of Tuberculosis and Respiratory Diseases, 44, 311-321.
[83] Wong, C., Jayaram, L., Karalus, N., et al. (2012) Azithromycin for Prevention of Exacerbations in Non-Cystic Fibrosis Bronchiec-tasis (EMBRACE): A Randomised, Double-Blind, Placebo-Controlled Trial. The Lancet, 380, 660-667. [Google Scholar] [CrossRef
[84] Serisier, D.J., Martin, M.L., McGuckin, M.A., et al. (2013) Effect of Long-Term, Low-Dose Erythromycin on Pulmonary Exacerbations among Patients with Non-Cystic Fibrosis Bronchiectasis: The BLESS Randomized Controlled Trial. Journal of the American Medical Association, 309, 1260-1267. [Google Scholar] [CrossRef] [PubMed]
[85] Altenburg, J., de Graaff, C.S., Stienstra, Y., et al. (2013) Effect of Azithromycin Maintenance Treatment on Infectious Exacerbations among Patients with Non-Cystic Fibrosis Bronchiec-tasis: The BAT Randomized Controlled Trial. The Journal of the American Medical Association, 309, 1251-1259. [Google Scholar] [CrossRef] [PubMed]
[86] Fan, L.C., Lin, J.L., Yang, J.W., et al. (2017) Macrolides Protect against Pseudomonas aeruginosa Infection via Inhibition of Inflammasomes. American Journal of Physiology-Lung Cellular and Molecular Physiology, 313, L677-L686. [Google Scholar] [CrossRef] [PubMed]
[87] Hodge, S., Tran, H.B., Hamon, R., et al. (2017) Nonantibiotic Macrolides Restore Airway Macrophage Phagocytic Function with Potential Anti-Inflammatory Effects in Chronic Lung Diseases. American Journal of Physiology-Lung Cellular and Molecular Physiology, 312, L678-L687. [Google Scholar] [CrossRef] [PubMed]
[88] Stevens, T., Ekholm, K., Granse, M., et al. (2011) AZD9668: Pharmacological Characterization of a Novel Oral Inhibitor of Neutrophil Elastase. Journal of Pharmacology and Ex-perimental Therapeutics, 339, 313-320. [Google Scholar] [CrossRef] [PubMed]
[89] King, P.T., Sharma, R., O’Sullivan, K.M., et al. (2017) Deoxyribonu-clease 1 Reduces Pathogenic Effects of Cigarette Smoke Exposure in the Lung. Scientific Reports, 7, Article No. 12128. [Google Scholar] [CrossRef] [PubMed]
[90] Brinkmann, V. and Zychlinsky, A. (2012) Neutrophil Extracel-lular Traps: Is Immunity the Second Function of Chromatin? The Journal of Cell Biology, 198, 773-783. [Google Scholar] [CrossRef] [PubMed]
[91] Chen, Z.G., Li, Y.Y., Wang, Z.N., et al. (2018) Aberrant Epithelial Remodeling with Impairment of Cilia Architecture in Non-Cystic Fibrosis Bronchiectasis. Journal of Thoracic Disease, 10, 1753-1764. [Google Scholar] [CrossRef] [PubMed]
[92] Tamaoki, J., Chiyotani, A., Kobayashi, K., et al. (1992) Effect of In-domethacin on Bronchorrhea in Patients with Chronic Bronchitis, Diffuse Panbronchiolitis or Bronchiectasis. American Review of Respiratory Disease, 145, 548-552. [Google Scholar] [CrossRef] [PubMed]
[93] Elborn, J.S., Johnstone, B., Allen, F., et al. (1992) Inhaled Steroids in Patients with Bronchiectasis. Respiratory Medicine, 86, 121-124. [Google Scholar] [CrossRef
[94] Rayner, C.F., Rutman, A., Dewar, A., et al. (1995) Ciliary Disorientation in Patients with Chronic Upper Respiratory Tract Inflammation. American Journal of Respiratory and Critical Care Medicine, 151, 800-804. [Google Scholar] [CrossRef
[95] Tarzi, M.D., Grigoriadou, S., Carr, S.B., Kuitert, L.M. and Longhurst, H.J. (2009) Clinical Immunology Review Series: An Approach to the Management of Pulmonary Disease in Primary Antibody Deficiency. Clinical & Experimental Immunology, 155, 147-155. [Google Scholar] [CrossRef] [PubMed]
[96] Chapel, H.M. (1994) Fortnightly Review: Concensus on Diagnosis and Management of Primary Antibody Deficiencies. BMJ, 308, Article No. 581. [Google Scholar] [CrossRef] [PubMed]
[97] Stubbs, A., Bangs, C., Shillitoe, B., et al. (2018) Bronchiectasis and Deteriorating Lung Function in Agammaglobulinaemia Despite Immunoglobulin Replacement Therapy. Clinical & Ex-perimental Immunology, 191, 212-219. [Google Scholar] [CrossRef] [PubMed]
[98] Sumitani, M., Tochino, Y., Kamimori, T., et al. (2008) Additive Inoculation of Influenza Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine to Prevent Lower Respiratory Tract Infections in Chronic Respiratory Disease Patients. Internal Medicine, 47, 1189-1197. [Google Scholar] [CrossRef] [PubMed]
[99] 成人支气管扩张症诊治专家共识编写组. 成人支气管扩张症诊治专家共识[J]. 中华结核和呼吸杂志, 2012, 35(7):485-492. [Google Scholar] [CrossRef
[100] Al-Jahdali, H., Alshimemeri, A., Mobeireek, A., et al. (2017) The Saudi Thoracic Society Guidelines for Diagnosis and Management of Noncystic Fibrosis Bronchiectasis. The Annals of Thoracic Surgery, 12, 135-161. [Google Scholar] [CrossRef